dc.contributor.author |
Guzman Vilca, Wilmer Cristobal |
|
dc.contributor.author |
Quispe-Villegas, Gustavo A. |
|
dc.contributor.author |
Váscones Román, Fritz Fidel |
|
dc.contributor.author |
Bernabé Ortiz, Antonio |
|
dc.contributor.author |
Carrillo Larco, Rodrigo Martín |
|
dc.date.accessioned |
2022-12-14T14:25:33Z |
|
dc.date.available |
2022-12-14T14:25:33Z |
|
dc.date.issued |
2022 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/12871 |
|
dc.description.abstract |
Objective To determine the agreement between the cardiovascular disease (CVD) risk predictions computed with the WHO non-laboratory-based model and laboratory-based model in a nationally representative sample of Peruvian adults. Design Cross-sectional analysis of a national health survey. Methods Absolute CVD risk was computed with the 2019 WHO laboratory-based and non-laboratory-based models. The risk predictions from both models were compared with Bland-Altman plots, Lin's concordance coefficient correlation (LCCC), and kappa statistics, stratified by sex, age, body mass index categories, smoking and diabetes status. Results 663 people aged 30-59 years were included in the analysis. Overall, there were no substantial differences between the mean CVD risk computed with the laboratory-based model 2.0% (95% CI 1.8% to 2.2%) and the non-laboratory-based model 2.0% (95% CI 1.8% to 2.1%). In the Bland-Altman plots, the limits of agreement were the widest among people with diabetes (-0.21; 4.37) compared with people without diabetes (-1.17; 0.95). The lowest agreement as per the LCCC was also seen in people with diabetes (0.74 (95% CI 0.63 to 0.82)), the same was observed with the kappa statistic (kappa=0.36). In general, agreement between the scores was appropriate in terms of clinical significance. Conclusions The absolute cardiovascular predicted risk was similar between the laboratory-based and non-laboratory-based 2019 WHO cardiovascular risk models. Pending validation from longitudinal studies, the non-laboratory-based model (instead of the laboratory-based) could be used when assessing CVD risk in Peruvian population. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
BMJ Group |
|
dc.relation.ispartofseries |
BMJ Open |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
laboratory-based |
en_US |
dc.subject |
cardiovascular risk |
en_US |
dc.subject |
national health survey |
en_US |
dc.subject |
Peru |
en_US |
dc.title |
Agreement between the laboratory-based and non-laboratory-based WHO cardiovascular risk charts: a cross-sectional analysis of a national health survey in Peru |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1136/bmjopen-2022-063289 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.04 |
|
dc.relation.issn |
2044-6055 |
|